Literature DB >> 7047291

The pharmacology of sulpiride--a dopamine receptor antagonist.

S E O'Connor, R A Brown.   

Abstract

1. The clinical and experimental pharmacology of sulpiride, its effects on the CNS, gastrointestinal tract and cardiovascular system have been reviewed. 2. The majority of its actions are attributable to blockade of dopamine receptors. 3. Although sulpiride has a high affinity for dopamine receptors involved in emesis and prolactin secretion, it lacks part of the behavioural and biochemical profiles of the classical dopamine receptor antagonist neuroleptics. 4. In the cardiovascular system, sulpiride is a potent prejunctional dopamine receptor antagonist but has variable effectiveness in postjunctional dopamine receptor models. 5. These properties are discussed with reference to the mechanisms of action of sulpiride and the classification of dopamine receptors.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7047291     DOI: 10.1016/0306-3623(82)90088-x

Source DB:  PubMed          Journal:  Gen Pharmacol        ISSN: 0306-3623


  15 in total

1.  Vasodilator response to dopamine in the ferret pulmonary circulation.

Authors:  P Gorman
Journal:  Br J Pharmacol       Date:  1988-05       Impact factor: 8.739

2.  Event-related potentials reflect impaired temporal interval learning following haloperidol administration.

Authors:  Sarah E Forster; Patrick Zirnheld; Anantha Shekhar; Stuart R Steinhauer; Brian F O'Donnell; William P Hetrick
Journal:  Psychopharmacology (Berl)       Date:  2017-06-10       Impact factor: 4.530

3.  Effects of amisulpride on human resting cerebral perfusion.

Authors:  Roberto Viviani; Heiko Graf; Maike Wiegers; Birgit Abler
Journal:  Psychopharmacology (Berl)       Date:  2013-04-13       Impact factor: 4.530

4.  Dissociated effects of apomorphine on various nociceptive responses in mice.

Authors:  F Gonzales-Rios; A Vlaiculescu; L Ben Natan; P Protais; J Costentin
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

5.  Differences in the time course of dopaminergic supersensitivity following chronic administration of haloperidol, molindone, or sulpiride.

Authors:  E S Prosser; R Pruthi; J G Csernansky
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

6.  Dopamine D2-like receptors and amino acid-induced glomerular hyperfiltration in humans.

Authors:  G Luippold; S Schneider; A Stefanescu; P Benöhr; B Mühlbauer
Journal:  Br J Clin Pharmacol       Date:  2001-05       Impact factor: 4.335

7.  Unexpected potentiation by discriminant benzamide derivatives of stereotyped behaviours elicited by dopamine agonists in mice.

Authors:  M Vasse; P Protais; J Costentin; J C Schwartz
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-04       Impact factor: 3.000

8.  Adrenoceptors and regulation of intestinal tone in the isolated colon of the mouse.

Authors:  J Fontaine; A Grivegnee; J Reuse
Journal:  Br J Pharmacol       Date:  1984-02       Impact factor: 8.739

9.  Sulpiride blocks postsynaptic dopamine receptors in the nucleus accumbens.

Authors:  R Morgenstern; H Fink
Journal:  J Neural Transm       Date:  1985       Impact factor: 3.575

10.  Comparative study of sulpiride and haloperidol on dopamine turnover in the rat brain.

Authors:  Y Imazu; K Kobayashi; T Shohmori
Journal:  Neurochem Res       Date:  1989-05       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.